TL-350, AN ERGOLINE DERIVATIVE WITH DOPAMINE RECEPTOR AGONIST PROPERTIES

被引：0
|
作者：
ILHAN, M
LONG, JP
BHATNAGAR, R
FLYNN, J
CANNON, JG
LEE, T
机构：
[1] UNIV IOWA,COLL MED,DEPT PHARMACOL,IOWA CITY,IA 52242
[2] UNIV IOWA,COLL PHARM,DEPT MECH CHEM & NAT PROD,IOWA CITY,IA 52242
来源：
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 1984年 / 231卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：56 / 60
页数：5
相关论文
共 50 条
  • [41] PARKINSON DISEASE TREATED WITH A SUSPECTED DOPAMINE RECEPTOR AGONIST
    CHASE, TN
    WOODS, AC
    GLAUBIGER, GA
    ARCHIVES OF NEUROLOGY, 1974, 30 (05) : 383 - 386
  • [42] AFFINITIES OF DRUGS FOR AGONIST AND ANTAGONIST STATES OF DOPAMINE RECEPTOR
    RIDDALL, DR
    LEAVENS, WJ
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1978, 51 (02) : 187 - 188
  • [43] SDZ 208-911, AN AMINO-ERGOLINE WITH PARTIAL DOPAMINE AGONIST PROPERTIES, DOSE-DEPENDENTLY INCREASES COCAINE SELF-ADMINISTRATION IN THE RAT
    PULVIRENTI, L
    SMITH, D
    KOOB, GF
    PSYCHOPHARMACOLOGY, 1994, 113 (3-4) : 518 - 520
  • [44] POSSIBLE DOPAMINE AGONIST PROPERTIES OF QUIPAZINE MALEATE
    FEIGENBAUM, JJ
    YANAI, J
    KLAWANS, HL
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 1983, 18 (3-4) : 205 - 210
  • [45] MIXED DOPAMINE AGONIST AND ANTAGONIST PROPERTIES OF LISURIDE
    GESSA, GL
    WESTFALL, TC
    BOI, V
    MEREU, G
    FEDERATION PROCEEDINGS, 1986, 45 (03) : 433 - 433
  • [46] A novel electrochemical sensor for non-ergoline dopamine agonist pramipexole based on electrochemically reduced graphene oxide nanoribbons
    Narayana, Prashanth S.
    Teradal, Nagappa L.
    Seetharamappa, J.
    Satpati, Ashis K.
    ANALYTICAL METHODS, 2015, 7 (09) : 3912 - 3919
  • [47] Possible neuroprotective properties of the dopamine agonist lisuride
    Horowski, R.
    Latte, K. P.
    Kranda, K.
    Flieger, M.
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S112 - S112
  • [48] CF 25-397 (9, 10-DIDEHYDRO-6-METHYL-8BETA-[2-PYRIDYLTHIOMETHYL] ERGOLINE), A NEW CENTRAL DOPAMINE RECEPTOR AGONIST
    JATON, AL
    LOEW, DM
    VIGOURET, JM
    BRITISH JOURNAL OF PHARMACOLOGY, 1976, 56 (03) : P371 - P371
  • [49] PHARMACOKINETIC AND PHARMACODYNAMIC PROPERTIES OF INTRAVENOUS FENOLDOPAM, A DOPAMINE1-RECEPTOR AGONIST, IN HYPERTENSIVE PATIENTS
    WEBER, RR
    MCCOY, CE
    ZIEMNIAK, JA
    FREDERICKSON, ED
    GOLDBERG, LI
    MURPHY, MB
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 25 (01) : 17 - 21
  • [50] Inverse agonist properties of dopaminergic antagonists at the D1A dopamine receptor:: Uncoupling of the D1A dopamine receptor from Gs protein
    Cai, GP
    Gurdal, H
    Smith, C
    Wang, HY
    Friedman, E
    MOLECULAR PHARMACOLOGY, 1999, 56 (05) : 989 - 996
12345